Your relationship with Medicare+Choice payors could be in for a shake-up in the new year. Beginning Jan. 1, M+C plan enrollees will have the right to an expedited review by a Quality Improvement Organization when they disagree with their M+C plan's decision that Medicare coverage of their home health agency, skilled nursing facility or comprehensive outpatient rehabilitation facility services should end, the Centers for Medicare & Medicaid Services pointed out in a recent notice to providers. HHAs, SNFs and CORFs will be responsible for delivering the first of the two termination notices required in the new process, and may be on the hook for many other appeals-related duties as well (see Eli's HCW, Vol. XII, No. 20, pp. 154-157). More information about the new process, which stems from the high-profile Grijalva lawsuit, is at www.cms.hhs.gov/medlearn/mcprogram.pdf. DAVE will be implemented nationally in January, CMS has announced. The project also aims to support quality improvement efforts, CMS integrity initiatives addressing payment accuracy, and payment policy development, the agency says. CMS has said it plans to share problems found via DAVE with surveyors. More information is at www.cms.hhs.gov/providers/psc/dave. Suppliers should use the code instead of billing separately for albuterol (J7618, J7619) and ipratropium (J7644), Palmetto explains. The request is at www.access.gpo.gov/su_docs/fedreg/a031212c.html. Meanwhile, Thompson named Dennis Smith as CMS Acting Administrator to temporarily replace Scully. Smith is Director of CMS' Center for Medicaid and State Operations. Deputy Administrator and Chief Operating Officer Leslie Norwalk will "continue to be the CMS lead in carrying out the Medicare legislation signed into law by the President last week," according to a CMS release. "Gentiva's CareCentrix unit will continue to coordinate and administer home care services for a substantial number of CIGNA HealthCare members, under capitated and fee-for-service arrangements" for an undisclosed sum, the Melville, NY-based company says. The services cover traditional home nursing, chronic and acute infusion therapies, and durable medical and respiratory equipment. The company's Hospital-to-Home program places a Praxair rep in the hospital to supply oxygen to patients who will be discharged needing home oxygen. If the patient chooses Praxair as its home oxygen provider, she doesn't have to repeat much of the administrative work done in the hospital, Mark Weise, director of Praxair's health care research and development, told the newspaper. "This is a way for us to take advantage of our stronger position in the hospitals and leverage in home care," Weise said. The fragmentation of the home care industry, with more than 2,000 oxygen providers nationwide, makes expansion via acquisitions attractive, Weise told the paper. The company is researching potential purchases. A number of home care companies, including Baton Rouge, LA-based Amedisys Inc., were left high and dry when their receivables were caught up in NCFE's collapse.